AI HEALTH TECH (01715) released its performance for the year 2025, with a net loss of 35.561 million yuan attributable to shareholders, a year-on-year decrease of 0.8%.
Wisdom Health Technology (01715) announced its annual performance for the year ending December 31, 2025, with a revenue of 47.404 million yuan, a year-on-year decrease of 48.4%; the company's attributable loss to owners was 35.561 million yuan, a year-on-year narrowing of 0.8%; basic loss per share was 0.13 yuan.
AI HEALTH TECH (01715) released its annual performance for the year ending on December 31, 2025, with a revenue of 47.404 million yuan, a year-on-year decrease of 48.4%; the company's attributable loss to shareholders was 35.561 million yuan, narrowing by 0.8% year-on-year; and the basic loss per share was 0.13 yuan.
During the reporting period, the group's gross profit margin increased to 9.0%, compared to 7.1% for the year ending on December 31, 2024, mainly due to changes in the product mix sold during the reporting period, and impairment losses on inventories of health-related products.
Related Articles

Guangzhou Automobile Group (02238) plans to sell a 12% equity stake in Xinjiang Kunlun Blue Diamond Mining Development Co., Ltd. for 1.92 billion yuan.

TEDA BIOMEDICAL (08189) released its annual performance with a net loss of 90.82 million yuan attributable to shareholders, an increase of 226.67% year-on-year.

Sandmartin International (00482) releases annual financial performance, with a net loss attributable to shareholders of HK$115 million, a year-on-year increase of 274.84%.
Guangzhou Automobile Group (02238) plans to sell a 12% equity stake in Xinjiang Kunlun Blue Diamond Mining Development Co., Ltd. for 1.92 billion yuan.

TEDA BIOMEDICAL (08189) released its annual performance with a net loss of 90.82 million yuan attributable to shareholders, an increase of 226.67% year-on-year.

Sandmartin International (00482) releases annual financial performance, with a net loss attributable to shareholders of HK$115 million, a year-on-year increase of 274.84%.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


